{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:41:27Z","timestamp":1788115287731,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.anpede.2024.503713","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T15:01:49Z","timestamp":1737385309000},"page":"503713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunisation schedule of the Pediatric Spanish Association: 2025 recommendations"],"prefix":"10.1016","volume":"102","author":[{"given":"Francisco Jos\u00e9","family":"\u00c1lvarez Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Iofr\u00edo de Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"\u00c1lvarez Alde\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Garrote Llanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"L\u00f3pez Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valent\u00edn","family":"Pineda Solas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Rivero Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Salamanca de la Cueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepe","family":"Serrano Marchuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Iofr\u00edo de Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"\u00c1lvarez Alde\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garc\u00e9s-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Garrote Llanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abi\u00e1n","family":"Montesdeoca Meli\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valent\u00edn","family":"Pineda Solas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Rivero Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepe","family":"Serrano Marchuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2024.503713_bib0005","doi-asserted-by":"crossref","first-page":"e1129","DOI":"10.1093\/cid\/ciac651","article-title":"Optimization of timing of maternal pertussis immunization from 6 years of postimplementation surveillance data in England","volume":"76","author":"Amirthalingam","year":"2023","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.anpede.2024.503713_bib0010","unstructured":"American College of Obstetricians and Gynecologists. ACOG. COVID-19 Vaccination Considerations for Obstetric-Gynecologic Care. Last updated September 25, 2023. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/12\/covid-19-vaccination-considerations-for-obstetric-gynecologic-care."},{"key":"10.1016\/j.anpede.2024.503713_bib0015","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Recomendaciones de vacunaci\u00f3n frente a gripe y COVID-19 en la temporada 2024-2025 en Espa\u00f1a. Actualizaci\u00f3n 6 de septiembre de 2024. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/gripe_covid19\/docs\/RecomendacionesVacunacion_Gripe-Covid19.pdf."},{"key":"10.1016\/j.anpede.2024.503713_bib0020","unstructured":"Documento de consenso del CAV-AEP y la SEGO. Vacunaci\u00f3n en el embarazo. Razones y bases de las recomendaciones. Madrid: AEP, SEGO; 2024 [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/vacunasaep.org\/documentos\/vacunacion-en-el-embarazo-documento-de-consenso-del-cav-aep-y-la-sego."},{"key":"10.1016\/j.anpede.2024.503713_bib0025","unstructured":"Centro Nacional de Epidemiolog\u00eda. Brote de tosferina en Espa\u00f1a, 2023-2024. Datos provisionales a 8 de julio de 2024. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/cne.isciii.es\/tosferina."},{"key":"10.1016\/j.anpede.2024.503713_bib0030","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2022.05.011","article-title":"SpIDnet VE study group. Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study","volume":"40","author":"Savulescu","year":"2022","journal-title":"Vaccine."},{"key":"10.1016\/j.anpede.2024.503713_bib0035","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1016\/S2589-7500(23)00108-5","article-title":"Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium","volume":"5","author":"Shaw","year":"2023","journal-title":"Lancet Digit Health."},{"key":"10.1016\/j.anpede.2024.503713_bib0040","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3201\/eid2808.220304","article-title":"Increased incidence of invasive pneumococcal disease among children after COVID-19 pandemic, England","volume":"28","author":"Bertran","year":"2022","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.anpede.2024.503713_bib0045","first-page":"23","article-title":"Enfermedad neumoc\u00f3cica invasiva en Espa\u00f1a. Periodo 2015-2021","volume":"31","author":"Soler-Soneira","year":"2023","journal-title":"Bol epidemiolsem [Internet]."},{"key":"10.1016\/j.anpede.2024.503713_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106204","article-title":"Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023)","volume":"89","author":"P\u00e9rez-Garc\u00eda","year":"2024","journal-title":"J Infect."},{"key":"10.1016\/j.anpede.2024.503713_bib0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.anpedi.2019.01.024","article-title":"\u00bfQu\u00e9 hemos aprendido sobre rotavirus en Espa\u00f1a en los \u00faltimos 10 a\u00f1os?","volume":"91","author":"D\u00edez-Domingo","year":"2019","journal-title":"An Pediatr (Engl Ed)."},{"key":"10.1016\/j.anpede.2024.503713_bib0060","unstructured":"Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Vacunaci\u00f3n en prematuros. Ministerio de Sanidad, Consumo y Bienestar Social, noviembre 2019. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/riesgo\/docs\/Vacunacion_Prematuros.pdf."},{"key":"10.1016\/j.anpede.2024.503713_bib0065","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Recomendaciones de vacunaci\u00f3n frente a rotavirus. 18 enero 2024. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/docs\/Rotavirus_Recomendaciones2024.pdf."},{"key":"10.1016\/j.anpede.2024.503713_bib0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.vaccine.2022.12.008","article-title":"Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006-2021","volume":"41","author":"Middleton","year":"2023","journal-title":"Vaccine."},{"key":"10.1016\/j.anpede.2024.503713_bib0075","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1017\/S0950268823000328","article-title":"Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review","volume":"151","author":"Pardo de Santayana","year":"2023","journal-title":"Epidemiol Infect."},{"key":"10.1016\/j.anpede.2024.503713_bib0080","series-title":"Annual epidemiological report for 2022","article-title":"Invasive meningococcal disease","year":"2024"},{"key":"10.1016\/j.anpede.2024.503713_bib0085","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2022.04.085","article-title":"Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation","volume":"40","author":"Rollier","year":"2022","journal-title":"Vaccine."},{"key":"10.1016\/j.anpede.2024.503713_bib0090","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/microorganisms8111681","article-title":"Why the anti-meningococcal B vaccination during adolescence should be implemented in Italy: an overview of available evidence","volume":"8","author":"Boccalini","year":"2020","journal-title":"Microorganisms."},{"key":"10.1016\/j.anpede.2024.503713_bib0095","article-title":"Measuring meningococcal vaccination coverage among adolescents in Italy: state-of-the-art and regional challenges","volume":"93","author":"Ferrara","year":"2022","journal-title":"Acta Biomed."},{"key":"10.1016\/j.anpede.2024.503713_bib0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2023.05.021","article-title":"4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation","volume":"87","author":"Wang","year":"2023","journal-title":"J Infect."},{"key":"10.1016\/j.anpede.2024.503713_bib0105","first-page":"185","article-title":"Vaccines against influenza: WHO position paper. May 2022","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec."},{"key":"10.1016\/j.anpede.2024.503713_bib0110","unstructured":"Ministerio de Sanidad. Recomendaciones de vacunaci\u00f3n frente a la gripe en poblaci\u00f3n infantil de 6 a 59 meses. Ponencia de Programa y Registro de Vacunaciones 2022. Espa\u00f1a: Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud; 2022 [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/docs\/Recomendaciones_vacunacion_gripe_PoblacionInfantil.pdf."},{"key":"10.1016\/j.anpede.2024.503713_bib0115","unstructured":"Wordl Health Organization. WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines. 2023 [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.1."},{"key":"10.1016\/j.anpede.2024.503713_bib0120","unstructured":"European Centre for Disease Prevention and Control. ECDC-EMA statement on updating COVID-19 vaccines composition for new SARS-CoV-2 virus variants- 7 Jun 2023. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.ecdc.europa.eu\/en\/news-events\/ecdc-ema-statement-updating-covid-19-vaccines-composition-new-sars-cov-2-virus-variants."},{"key":"10.1016\/j.anpede.2024.503713_bib0125","unstructured":"Ponencia de Alertas, Planes de Preparaci\u00f3n y Respuesta. La covid-19 tras el fin de la emergencia sanitaria. Nuevo marco estrat\u00e9gico integrado en la vigilancia y Control de las infecciones respiratorias agudas. Espa\u00f1a: Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud; 2023 [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.sanidad.gob.es\/areas\/alertasEmergenciasSanitarias\/alertasActuales\/nCov\/documentos\/Nuevo_marco_estrategico_COVID-19_05072023.pdf."},{"key":"10.1016\/j.anpede.2024.503713_bib0130","unstructured":"Comit\u00e9 Asesor de Vacunas e Inmunizaciones (CAV-AEP). Virus SARS-CoV-2. Manual de inmunizaciones en l\u00ednea de la AEP. Madrid: AEP; Dec 2024. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/vacunasaep.org\/documentos\/manual\/cap-44."},{"key":"10.1016\/j.anpede.2024.503713_bib0135","unstructured":"Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias, Ministerio de Sanidad. Evaluaci\u00f3n r\u00e1pida de riesgo. Implicaciones para Espa\u00f1a del aumento de casos y brotes de sarampi\u00f3n a nivel mundial y europeo. Espa\u00f1a: Ministerio de Sanidad; 2024 [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/www.sanidad.gob.es\/areas\/alertasEmergenciasSanitarias\/alertasActuales\/sarampion\/docs\/20240617_Sarampion_ERR.pdf."},{"key":"10.1016\/j.anpede.2024.503713_bib0140","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s10096-021-04298-z","article-title":"The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study","volume":"40","author":"Rafferty","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.anpede.2024.503713_bib0145","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.anpede.2024.503713_bib0150","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/vaccines11061083","article-title":"Impact of human papillomavirus vaccination on male disease: a systematic review","volume":"11","author":"Rosado","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.anpede.2024.503713_bib0155","first-page":"101","article-title":"Update on safety and efficacy of HPV vaccines: focus on Gardasil","volume":"10","author":"Soliman","year":"2021","journal-title":"Int J Mol Cell Med."},{"key":"10.1016\/j.anpede.2024.503713_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290808","article-title":"The clinical effectiveness of one-dose vaccination with an HPV vaccine: a meta-analysis of 902,368 vaccinated women","volume":"19","author":"Setiawan","year":"2024","journal-title":"PLoS One."},{"key":"10.1016\/j.anpede.2024.503713_bib0165","unstructured":"Grupo de trabajo de Recomendaciones de Vacunaci\u00f3n frente a VPH de la Ponencia de Programa y Registro de Vacunaciones. Actualizaci\u00f3n de las recomendaciones de vacunaci\u00f3n frente a VPH. Revisi\u00f3n de la estrategia de una dosis. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, julio 2024. [Internet]. [Accessed 15 Dec 2024]. Available from: https:\/\/web.mscbs.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/docs\/VPH_recomendaciones_vacunacion_estrategia1dosis.pdf."},{"key":"10.1016\/j.anpede.2024.503713_bib0170","article-title":"Nirsevimab effectiveness against RSV hospital admission in children under 1 year of age: a Spanish population-based case control study","author":"Nu\u00f1ez","year":"2024","journal-title":"Lancet."},{"key":"10.1016\/j.anpede.2024.503713_bib0175","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13294","article-title":"SARI Sentinel Surveillance RSV Study Group. Estimated impact of nirsevimab on the incidence of respiratory syncytial virus infections requiring hospital admission in children < 1 year, weeks 40, 2023, to 8, 2024, Spain","volume":"18","author":"Mazagatos","year":"2024","journal-title":"Influenza Other Respir Viruses."},{"key":"10.1016\/j.anpede.2024.503713_bib0180","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1473-3099(24)00215-9","article-title":"NIRSE-GAL study group. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study","volume":"24","author":"Ares-G\u00f3mez","year":"2024","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.anpede.2024.503713_bib0185","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.6.2400046","article-title":"Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024","volume":"29","author":"L\u00f3pez-Lacort","year":"2024","journal-title":"Euro Surveill."},{"key":"10.1016\/j.anpede.2024.503713_bib0190","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/archdischild-2024-327153","article-title":"Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain)","volume":"109","author":"Coma","year":"2024","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.anpede.2024.503713_bib0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/vaccines12040383","article-title":"Effectiveness of nirsevimab immunoprophylaxis administered at birth to prevent infant hospitalisation for respiratory syncytial virus infection: a population-based cohort study","volume":"12","author":"Ezpeleta","year":"2024","journal-title":"Vaccines."},{"key":"10.1016\/j.anpede.2024.503713_bib0200","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1441786","article-title":"The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study","volume":"12","author":"Barbas Del Buey","year":"2024","journal-title":"Front Public Health."}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287924003296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287924003296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T21:33:14Z","timestamp":1737667994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287924003296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2341287924003296"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2024.503713","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunisation schedule of the Pediatric Spanish Association: 2025 recommendations","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2024.503713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2024.503713","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"503713"}}